Axogen (AXGN) Non Operating Income (2010 - 2026)
Axogen's (AXGN) quarterly Non Operating Income came in at -$16.8 million in Q1 2026, down 670.92% year-on-year from $2.9 million in Q1 2025, and down 395.04% quarter-over-quarter from -$3.4 million in Q4 2025.
Axogen (AXGN) Non Operating Income (2010 - 2026) Analysis & Trends
Axogen's Non Operating Income history runs 17 years deep, the most recent figure standing at -$16.8 million for Q1 2026.
- On a quarterly basis, Non Operating Income fell 670.92% year-over-year to -$16.8 million in Q1 2026; TTM through Mar 2026 was -$22.4 million, a 231.11% decrease from a year earlier, with the FY2025 full-year figure at -$7.9 million, down 17.63% from the prior year.
- Non Operating Income declined to -$16.8 million in Q1 2026 per AXGN's latest filing, from -$3.4 million in the prior quarter.
- Across five years, Non Operating Income topped out at $537000.0 in Q3 2022 and bottomed at -$16.8 million in Q1 2026.
- The 5-year median for Non Operating Income is -$1.1 million (2025), against an average of -$1.8 million.
- Across the five-year window, Non Operating Income jumped 272.26% in 2023 and tumbled 2309.38% in 2024, its largest moves.
- Year by year, Non Operating Income stood at $193000.0 in 2022, then plunged by 462.18% to -$699000.0 in 2023, then tumbled by 124.18% to -$1.6 million in 2024, then sank by 115.95% to -$3.4 million in 2025, then slumped by 395.04% to -$16.8 million in 2026.
- Per Business Quant, the three latest AXGN Non Operating Income figures stand at -$16.8 million (Q1 2026), -$3.4 million (Q4 2025), and -$1.2 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | -16.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.75 Mn |
| Dec 31, 2025 | -3.38 Mn |
| Sep 30, 2025 | -1.20 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | -2.17 Mn |
| Dec 31, 2024 | -1.57 Mn |
| Sep 30, 2024 | -1.54 Mn |
| Jun 30, 2024 | -1.49 Mn |
| Mar 31, 2024 | -2.08 Mn |
| Dec 31, 2023 | -699,000.00 |
| Sep 30, 2023 | -64,000.00 |
| Jun 30, 2023 | 242,000.00 |
| Mar 31, 2023 | 267,000.00 |
| Dec 31, 2022 | 193,000.00 |
| Sep 30, 2022 | 537,000.00 |
| Jun 30, 2022 | 184,000.00 |
| Mar 31, 2022 | -155,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | -452,000.00 |
| Jun 30, 2021 | -744,000.00 |